Lung Cancer Treatment Breakthrough and Box Office Hits

This chapter highlights the promising results of Ivonescimab, a bi-specific antibody treatment for lung cancer, before shifting gears to discuss the impressive opening weekend performance of Beetlejuice at the box office. It concludes with a financial analysis of Wall Street's stock market, particularly regarding potential tax loss implications as the year ends.